gebundene Ausgabe. Condition: Gut. 500 Seiten Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber und kann entsprechende Merkmale aufweisen (Rückenschild, Instituts-Stempel.). In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 890.
Seller: Anybook.com, Lincoln, United Kingdom
Condition: Good. Volume 155. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,950grams, ISBN:9783540424123.
Language: English
Published by The University Press of Kentucky, 2024
ISBN 10: 0813199220 ISBN 13: 9780813199221
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Seller: BOOKWEST, Phoenix, AZ, U.S.A.
First Edition
Hardcover. Condition: Very Good. 1st Edition. US SELLER SHIPS FAST FROM USA.
Language: English
Published by The University Press of Kentucky, 2024
ISBN 10: 0813199220 ISBN 13: 9780813199221
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Condition: New.
Condition: As New. Unread book in perfect condition.
Seller: Antiquariat Buchkauz, Herzogenburg, Austria
First Edition
8°, hardcover. Condition: Gut. first Edition. 455 S. Dustjacket, good condition Sprache: Englisch Gewicht in Gramm: 1100.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 240 pages. 9.00x6.00x0.63 inches. In Stock.
Condition: Très bon.
Language: English
Published by University Press of Kentucky, 2024
ISBN 10: 0813199212 ISBN 13: 9780813199214
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Paperback. Condition: Brand New. 158 pages. 9.00x6.00x0.40 inches. In Stock.
Hardcover. Condition: Very Good. No Jacket. Former library book; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Language: English
Published by University Press of Kentucky, 2024
ISBN 10: 0813199212 ISBN 13: 9780813199214
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Language: English
Published by All Digital Future Llp, 2023
ISBN 10: 9811864438 ISBN 13: 9789811864438
Seller: Rarewaves USA, OSWEGO, IL, U.S.A.
Hardback. Condition: New.
Condition: New. pp. xii + 155.
Language: English
Published by All Digital Future LLP, 2023
ISBN 10: 9811864438 ISBN 13: 9789811864438
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 400 pages. 11.00x1.19x8.50 inches. In Stock.
Seller: BOOKWEST, Phoenix, AZ, U.S.A.
First Edition
Hardcover. Condition: New. 1st Edition. NEW SHRINK-WRAPPED: US SELLER SHIPS FAST FROM USA.
Language: English
Published by All Digital Future Llp, 2023
ISBN 10: 9811864438 ISBN 13: 9789811864438
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
£ 134.12
Quantity: Over 20 available
Add to basketHardback. Condition: New.
Language: English
Published by All Digital Future Llp, 2023
ISBN 10: 9811864438 ISBN 13: 9789811864438
Seller: Rarewaves USA United, OSWEGO, IL, U.S.A.
Hardback. Condition: New.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. reprint edition. 167 pages. 9.50x6.00x0.50 inches. In Stock.
Seller: Revaluation Books, Exeter, United Kingdom
Hardcover. Condition: Brand New. 242 pages. 9.00x6.00x9.00 inches. In Stock.
Taschenbuch. Condition: Neu. Glutamate, Cell Death and Memory | Philippe Ascher (u. a.) | Taschenbuch | xii | Englisch | 2011 | Springer | EAN 9783642845284 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Language: English
Published by Springer Berlin Heidelberg, 2011
ISBN 10: 3642845282 ISBN 13: 9783642845284
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - In the past few years, the Fondation IPSEN has been increasing its activity in the neurosciences, especially by supporting researchers working on Alzheimer's disease. This interest in the subject is demonstrated by a prize and a fellowship, which have been awarded each year since 1985, a monthly newsletter, and a series of Colloques Medecine et Recherche and their proceedings which are distributed world-wide. Since 1990, our effort in the field of neuroscience has been considerably enhanced. A new series of Colloques Medecine et Recherche has been devoted to this topic. Like the meetings on Alzheimer's disease, this series will deal with the most current research. Glutamate -the subject we chose for the first meeting of this series - is an excellent example since it has a major role in many physiological or pathological situations. This book contains the proceedings of the meeting which was held in Paris on September 24, 1990. As for the proceedings of the meeting on Alzheimer's disease - published in the series Research and Perspectives in Alzheimer's disease -these meetings will be reported in a new series, distributed at an international level, Research and Perspectives in Neurosciences. The second meeting on neurosciences is scheduled for September 23, 1991, and will be held in Paris. It will be dedicated to Gene transfer and therapy in the nervous system (Organizing Committee: F. Gage, La Jolla; Y. Christen, Paris).
Condition: Sehr gut. Zustand: Sehr gut | Seiten: 524 | Sprache: Englisch | Produktart: Bücher | "CNS neuroprotection" was a common subject of papers, symposia, and reviews during the previous "decade of the brain. " Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, "Mechanistic Approaches to CNS Neuroprotection," reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.
Hardcover. Condition: Brand New. 147 pages. 9.00x6.00x0.75 inches. In Stock.
Language: English
Published by All Digital Future Llp, 2023
ISBN 10: 9811864438 ISBN 13: 9789811864438
Seller: Rarewaves.com UK, London, United Kingdom
£ 122.18
Quantity: Over 20 available
Add to basketHardback. Condition: New.
Condition: Sehr gut. Zustand: Sehr gut | Seiten: 528 | Sprache: Englisch | Produktart: Bücher | "CNS neuroprotection" was a common subject of papers, symposia, and reviews during the previous "decade of the brain. " Indeed, in recent years, experimental study of putative neuroprotective agents prompted clinical trials of numerous drug candidates in acute and chronic human neurodegenerative conditions. While the outcomes of these trials have not been as successful as initially hoped, these were early explorations, and the pipeline of relevant ideas continues to grow in strength and depth. We predict that early in this new millennium, crippling disorders such as stroke and Alzheimer's disease will be treated effectively by therapeutic neuroprotective strategies. This volume of the Handbook of Experimental Pharmacology titled eNS Neuroprotection provides a pharmacological perspective on currently promis ing neuroprotective approaches, and a clinical perspective on the challenges involved in establishing the efficacy of these approaches through appropriate clinical trials. Section I, "Mechanistic Approaches to CNS Neuroprotection," reviews major injury mechanisms that have formed the basis for many past and present clinical trials conducted around the world. Dr. KIM and colleagues, Washington University School of Medicine, review the status of blocking excitotoxicity as an approach to CNS neuroprotection. Dr. WANG, Pfizer Global Research and Development,Ann Arbor Laboratories, outlines evidence supporting a contri bution of apoptosis to pathological neuronal or glial cell loss. Drs. BECKER and HALLENBECK, University of Washington and the National Institute on Neuro logical Diseases and Stroke, respectively, argue that inhibiting inflammatory pathways in the brain can be neuroprotective. Dr.